First, master regulators of cell cholesterol homeostasis are already deregulated in primary cancer, with a decreased expression of NR1H2, coding for LXRβ, which is associated with the management of excess cholesterol (Figure 8A). This evidence concerns the gene NR1H2 and cancer.